|
FAM190B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.46429535163861E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.15170145326738E-11 |
| Normal-vs-Stage2 |
2.27139995701009E-09 |
| Normal-vs-Stage3 |
1.90130133859157E-11 |
| Normal-vs-Stage4 |
3.3983926783776E-13 |
| Stage1-vs-Stage2 |
8.294200E-01 |
| Stage1-vs-Stage3 |
2.923800E-01 |
| Stage1-vs-Stage4 |
1.975800E-02 |
| Stage2-vs-Stage3 |
6.172200E-01 |
| Stage2-vs-Stage4 |
8.787900E-02 |
| Stage3-vs-Stage4 |
1.856410E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.51672033108252E-12 |
| Normal-vs-AfricanAmerican |
3.9376999999563E-06 |
| Normal-vs-Asian |
6.34819974365541E-10 |
| Caucasian-vs-AfricanAmerican |
1.367020E-01 |
| Caucasian-vs-Asian |
7.601200E-01 |
| AfricanAmerican-vs-Asian |
2.697000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.63085167171585E-12 |
| Normal-vs-Female |
2.70170552596483E-11 |
| Male-vs-Female |
4.808600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.29259952636107E-10 |
| Normal-vs-Age(41-60Yrs) |
1.20403687020598E-12 |
| Normal-vs-Age(61-80Yrs) |
1.22679977287987E-10 |
| Normal-vs-Age(81-100Yrs) |
5.780700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.026000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.246800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.277800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.276200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.735200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.751200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.127600E-01 |
| Classical-VS-Follicular |
2.231400E-01 |
| Classical-VS-Other |
2.979800E-01 |
| Classical-VS-Normal |
5.99420513225368E-11 |
| Tall-VS-Follicular |
1.082360E-01 |
| Tall-VS-Other |
5.030000E-01 |
| Tall-VS-Normal |
3.21199955521934E-10 |
| Follicular-VS-Other |
2.275200E-01 |
| Follicular-VS-Normal |
4.03430000517346E-09 |
| Other-VS-Normal |
1.85649999995263E-06 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.97537599797715E-12 |
| Normal-vs-N1 |
1.0315970300212E-11 |
| N0-vs-N1 |
2.991400E-01 |
|
|
